// App-Quantinova.ai

: Impact of body mass index in newly diagnosed atrial fibrillation in the GARFIELD-AF registry

Researchers

Presenter

  • S.Z. Goldhaber

Principal Investigators

  • J.P. Bassand

  • G. Accetta

  • A.J. Camm

  • S. Goto

  • G. Kayani

  • F. Misselwitz

  • A.G.G. Turpie

  • A.K. Kakkar

Medical Centers

  • Harvard Medical School - Boston - United States of America

  • Thrombosis Research Institute, London, UK & University of Besançon, Besancon, France

  • Thrombosis Research Institute, London, United Kingdom

  • St George's, University of London, London, United Kingdom

  • Tokai University School of Medicine, Isehara, Japan

  • Bayer, Berlin, Germany

  • Thrombosis Research Institute and University College London, London, United Kingdom

Locations

  • France

  • United Kingdom

  • Japan

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Bayer AG

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved